User login
December 2020 Journal Scans and Expert Commentary
Dr. Marc Wein: Clinicians should consider increase in atrial fibrillation risk in the setting of other cardiac comorbidities when selecting anti-resorptive therapy for osteoporosis
- Risk factors for osteoporosis in CHF patients
- Switching to denosumab prevents osteoporosis progression in postmenopausal women with T2D
- Higher prevalence of periapical lesions in patients with osteoporosis
- Protective action of impaired fasting glucose on osteoporosis risk
- Psoriasis tied to increased risk for osteoporosis
- Efficacy of romosozumab followed by denosumab in women at high risk of fracture
- Denosumab not linked to malignancy risk in patients with osteoporosis
- Corticosteroids for asthma could raise osteoporosis and fragility fracture risk
- Zoledronic acid treatment for osteoporosis modestly raises AFib risk
- BMD and bone turnover after gastric bypass vs. sleeve gastrectomy
November 2020 Journal Scans and Expert Commentary
Dr. Marc Wein: Extra attention should be paid to fracture risk in COPD patients receiving high-dose inhaled corticosteroids
- Hypogonadism is a key risk factor for fractures in glucocorticoid-induced osteoporosis
- Forearm BMD and fracture incidence in postmenopausal women with osteoporosis
- High-dose ICS tied to osteoporosis and fracture risk in COPD
- Minodronate shows better clinical efficacy than comparators in meta-analysis
- Lumbar spine BMD inversely linked to coronary artery calcification in patients with osteoporosis
- MetS linked to increased risk for low BMD in women with suspected osteoporosis
- Serum vitamin K1 inversely related to fracture risk in postmenopausal osteoporosis
- Age-related macular degeneration tied to fracture risk in patients with osteoporosis
October 2020 Journal Scans and Expert Commentary
Dr. Marc Wein: Risks of vertebral fractures linked to rapid cessation of denosumab must be carefully considered
- Osteoporosis: Predictors of vertebral fracture risk in patients receiving denosumab
- SGLT2 inhibitors with metformin do not influence fracture risk
- Sepsis and osteoporosis: What’s the link?
- Osteoporosis increases likelihood of revision surgery after long spinal fusion for adult spinal deformity
- Metformin may attenuate osteoporosis risk in diabetic patients with carcinoma in situ
- Teriparatide can be considered in premenopausal women with idiopathic osteoporosis
- Denosumab safe and effective in chronic liver disease patients with osteoporosis
September 2020 Journal Scans and Expert Commentary
Dr. Marc Wein: Study data support the cardiac safety of PTH analogs for osteoporosis
- Glucocorticoid-induced osteoporosis: Teriparatide may be a good alternative to denosumab
- Psoriatic arthritis, psoriasis, and osteoporosis: What is the association?
- Osteoporosis: Cardiovascular safety of abaloparatide in postmenopausal women
- Initiation of antiosteoporotic drugs in women starting glucocorticoid treatment
- Delayed denosumab injections raise vertebral fracture risks in osteoporosis
- Association between serum magnesium concentration and postmenopausal osteoporosis
- Postmenopausal osteoporosis: Factors influencing early treatment with romosozumab
- Pro-inflammatory diets tied to osteoporosis risk
- Risk factors for osteosarcopenia in postmenopausal women with osteoporosis
- Asthma tied to increased risk of osteoporosis and fragility fractures